NEO Neogenomics Inc

$11.13 +7.17%

Industrials · Services-Testing Laboratories

Neogenomics Inc (NEO) is a industrials company in the Services-Testing Laboratories industry, with a market capitalization of $1.4 billion. Shares last traded at $11.13, 18.2% below their 52-week high. Over the past year the stock is up 59.1%. Net profit margin is -14.8%, in line with the peer median of -14.8%. Revenue grew 10.1% year over year.

Market Cap

$1.4B

Shares Out

130.2M

EPS (TTM)

$-0.44

P/E Ratio

—

P/S Ratio

1.99

P/B Ratio

1.75

Dividend / Share

—

Dividend Yield

—

52-Week High

$13.62

52-Week Low

$4.71

Volume

232,696

Avg Vol (3m)

118,778.794

Performance

-3.09%

+32.88%

+35.96%

-4.54%

YTD

-5.23%

+59.07%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

61.08

SMA (50)

$9.32

SMA (200)

$10.00

Price vs SMA50

+19.47%

Price vs SMA200

+11.40%

ATR (14)

$1.24

Financials

Revenue

$727M

Net Income

$-108M

Gross Margin

43.2%

Operating Margin

-15.9%

Net Margin

-14.8%

Return on Equity

-13.0%

Return on Assets

-8.0%

Current Ratio

4.42

Debt / Equity

0.41

Revenue Growth (YoY)

+10.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2016	$-0.21	2016-11-07
Q2 2016	$-0.14	2016-08-05
Q1 2016	$-0.07	2016-05-10
FY 2015	$-0.04	2016-04-18
Q3 2016	$-0.02	2016-11-07
Q2 2016	$-0.02	2016-08-05

Full earnings history →

Services-Testing Laboratories peers

NEO vs 4 industry peers (Services-Testing Laboratories), by market cap.

P/S vs peers

1.99 / 1.99 med

+0% premium

Net margin vs peers

-14.8% / -14.8% med

above median

1–4 of 4


ULS	Ul Solutions Inc.	$18.4B	—	—	—	-2.88%
NEO	Neogenomics Inc	$1.4B	-13.43	1.99	-14.8%	+7.17%
AIDX	20/20 Biolabs, Inc.	$7M	—	—	—	+0.18%
BNBX	BNB PLUS CORP.	$3M	-0.21	—	—	-6.58%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.